Clinical Trial Update: QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas [Phase 3]

View source ↗

Summary

This Phase 3 trial update reports completion of QUILT-2.014 evaluating gemcitabine with ganitumab (AMG 479) in metastatic pancreatic cancer, with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Ganitumab (ganitumab)
• Gemzar (gemcitabine)

Snippet

Sponsor: NantCell, Inc. | Conditions: Adenocarcinoma of the Pancreas, Advanced Solid Tumors | Phase 3 | Status: COMPLETED | Results posted: 2024-07-16